Search

Filters

Clear Filters
5:00 PM - 5:05 PM ET

1018 - Phase 1 Trial of CT-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for Treatment of Ultra-Central Early-Stage Non-Small Cell Lung Cancer (NSCLC)
Speaker: D'Souza, Alden, MD, MPHS - Washington University School of Medicine, Saint Louis, MO
5:05 PM - 5:10 PM ET

1019 - SARS-CoV-2 mRNA Vaccination is Associated with Improved Clinical Outcomes in Early-Stage NSCLC Treated with Stereotactic Ablative Radiotherapy
Speaker: Xu, Xinyan, MD - MD Anderson Cancer Center, Houston, TX
3:20 PM - 3:30 PM ET

102 - Multi-Institutional Development and Prospective Validation of a Vision-Language Model for Prostate MRI Segmentation and Prognostication
Speaker: King, Martin, MD, PhD - Brigham and Women's Hopsital, Boston, MA
5:10 PM - 5:15 PM ET

1020 - Prospective Study of Surface Guided Radiation Therapy (SGRT) Alone or in Combination with Fiducials for Free Breathing (FB) vs. Breath Hold (BH) Stereotactic Body Radiation Therapy (SBRT) Treatments of the Lung
Speaker: Heinzerling, John, MD - Atrium Health Levine Cancer, Wake Forest School of Medicine, Southeast Radiation Oncology Group PA, Charlotte, NC
5:15 PM - 5:20 PM ET

1021 - Adebrelimab as Maintenance Therapy Following Hyperfractionated Simultaneous Integrated Boost Radiotherapy Plus Chemotherapy in Limited-Stage Small-Cell Lung Cancer: A Prospective, Multicenter, Single-Arm Phase II Trial
Speaker: Yu, Jiayi, PhD - Peking University Cancer Hospital and Institute, Beijing, Beijing
5:20 PM - 5:25 PM ET

1022 - Optimizing Nodal Target Delineation in Limited-Stage Small Cell Lung Cancer: A Large-Scale, Multi-Institutional Study
Speaker: Wang, Xiaolong - Cancer Center, Shandong University, Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong, Jin, jinan
5:25 PM - 5:30 PM ET

1023 - Induction Immunochemotherapy followed by Definitive Radiotherapy in Patients with Limited-Stage Small Cell Lung Cancer: A Multicenter Study
Speaker: Wen, Junxu - Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong
8:05 AM - 8:10 AM ET

1024 - TP53 Mutations in Primary Breast Tumors Predict Brain Metastases: Insights from the MSK CHORD Cohort
Speaker: Lee, Victor, MD, BS - Yale New Haven Hospital, Middletown, CT
8:10 AM - 8:15 AM ET

1025 - Association of the Radiosensitivity Index with Overall Survival In Radiotherapy-Treated HER2+ and Triple-Negative Breast
Speaker: Nellore, Shivani - Cleveland Clinic, Cleveland, OH
8:15 AM - 8:20 AM ET

1026 - Intratumoral Immune Remodeling and Tumor Regression following Preoperative Radiation in Estrogen Receptor Positive Breast Cancer: Results from a Prospective Clinical Trial
Speaker: SenthilKumar, Gopika, BS - University of Wisconsin, Madison, WI
8:20 AM - 8:25 AM ET

1027 - Association of Blood Count-Derived Inflammatory Indices with Capsular Contracture After Post-Mastectomy Radiotherapy in Breast Cancer Patients Undergoing Direct-to-Implant Reconstruction
Speaker: Lee, Jae Young, MD - Department of Radiation Oncology, Yonsei University College of Medicien, Yonsei Cancer Center, Seoul
8:25 AM - 8:30 AM ET

1028 - Comparable Cosmetic Outcomes Across Racial and Age Groups After Dose-Escalated Five-Fraction Stereotactic Partial Breast Irradiation (S-PBI) on a Phase II Multicenter Trial
Speaker: Bolton, Chelsea - University of Texas Southwestern Medical Center at Dallas, Dallas, TX